Biblio

Export 3166 results:
Author Title Type [ Year(Asc)]
2022
E. Lacorte, Ancidoni, A., Zaccaria, V., Remoli, G., Tariciotti, L., Bellomo, G., Sciancalepore, F., Corbo, M., Lombardo, F. L., Bacigalupo, I., Canevelli, M., Piscopo, P., and Vanacore, N., Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials., J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging., J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
Y. Peng, Zhang, L., Zhou, F., Wang, Y., Zhang, X., Fan, J., Li, S., Li, X., and Li, Y., Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells., J Alzheimers Dis, vol. 90, no. 1, pp. 185-198, 2022.
P. Kundu, Zimmerman, B., Quinn, J. F., Kaye, J., Mattek, N., Westaway, S. K., and Raber, J., Serum Levels of α-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function., J Alzheimers Dis, vol. 86, no. 3, pp. 1471-1481, 2022.
A. Sil, Erfani, A., Lamb, N., Copland, R., Riedel, G., and Platt, B., Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model., J Alzheimers Dis, vol. 85, no. 2, pp. 755-778, 2022.
F. Rahmani, Wang, Q., McKay, N. S., Keefe, S., Hantler, N., Hornbeck, R., Wang, Y., Hassenstab, J., Schindler, S., Xiong, C., Morris, J. C., Benzinger, T. L. S., and Raji, C. A., Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity., J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
S. Hannonen, Andberg, S., Kärkkäinen, V., Rusanen, M., Lehtola, J. - M., Saari, T., Korhonen, V., Hokkanen, L., Hallikainen, M., Hänninen, T., Leinonen, V., Kaarniranta, K., Bednarik, R., and Koivisto, A. M., Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
A. E. Weller, Ferraro, T. N., Doyle, G. A., Reiner, B. C., Crist, R. C., and Berrettini, W. H., Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology., J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.
C. Tong Lio, Kacprowski, T., Klaedtke, M., Jensen, L. R., Bouter, Y., Bayer, T. A., and Kuss, A. W., Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease., J Alzheimers Dis, vol. 87, no. 4, pp. 1671-1681, 2022.
J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals., J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
D. Aschwanden, Sutin, A. R., Ledermann, T., Luchetti, M., Stephan, Y., Sesker, A. A., Zhu, X., and Terracciano, A., Subjective Cognitive Decline: Is a Resilient Personality Protective Against Progression to Objective Cognitive Impairment? Findings from Two Community-Based Cohort Studies., J Alzheimers Dis, vol. 89, no. 1, pp. 87-105, 2022.
J. M. Nolan, Power, R., Howard, A. N., Bergin, P., Roche, W., Prado-Cabrero, A., Pope, G., Cooke, J., Power, T., and Mulcahy, R., Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
C. F. M. Huffels, van Dijk, R. E., Karst, H., Meye, F. J., Hol, E. M., and Middeldorp, J., Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1., J Alzheimers Dis, vol. 89, no. 1, pp. 283-297, 2022.
J. Lynn, Park, M., Ogunwale, C., and Acquaah-Mensah, G. K., A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 485-501, 2022.
G. Eastman, Sharlow, E. R., Lazo, J. S., Bloom, G. S., and Sotelo-Silveira, J. R., Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice., J Alzheimers Dis, vol. 86, no. 1, pp. 365-386, 2022.
M. M. Mielke, Ransom, J. E., Mandrekar, J., Turcano, P., Savica, R., and Brown, A. W., Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population., J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
R. McGrath, Robinson-Lane, S. G., Klawitter, L., Rhee, Y., Hamm, J. M., McCourt, M. E., Parker, K., and Hackney, K. J., Undiagnosed Dementia Is Associated with Poor Physical Function in Older Adults., J Alzheimers Dis, vol. 89, no. 2, pp. 473-482, 2022.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
V. Fleming, Helsel, B. C., Ptomey, L. T., H Rosas, D., Handen, B., Laymon, C., Christian, B. T., Head, E., Mapstone, M., Lai, F., Krinsky-McHale, S., Zaman, S., Ances, B. M., Lee, J. H., and Hartley, S. L., Weight Loss and Alzheimer's Disease in Down Syndrome., J Alzheimers Dis, vol. 91, no. 3, pp. 1215-1227, 2022.
B. Krause-Sorio, Siddarth, P., Kilpatrick, L., Milillo, M. M., Aguilar-Faustino, Y., Ercoli, L., Narr, K. L., Khalsa, D. S., and Lavretsky, H., Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 87, no. 2, pp. 569-581, 2022.
K. Metsla, Kirss, S., Laks, K., Sildnik, G., Palgi, M., Palumaa, T., Tõugu, V., and Palumaa, P., α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 2, pp. 715-728, 2022.

Pages